Concepedia

Gregory Logan

GL

Statistics

Publications

3

Citations

373

H-Index

3

Active since

2016

Affiliations

GlaxoSmithKline (United States)(Current)

Gregory Logan is an author at GlaxoSmithKline (United States) specializing in life sciences, pharmacology, and nrf2 pathway activation.

Publications per year

2016–2017

3

Publications

3

Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein–Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery

Thomas G. Davies, William E. Wixted, Joseph E. Coyle et al. · Journal of Medicinal Chemistry · 2016 · 306 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

Merkel cells are long-lived cells whose production is stimulated by skin injury

Margaret C. Wright, Gregory Logan, Alexa M. Bolock et al. · Developmental Biology · 2016 · 47 citations

Life Sciences, Cell Biology, Immunology +6

Characterization of the Potent, Selective Nrf2 Activator, 3-(Pyridin-3-Ylsulfonyl)-5-(Trifluoromethyl)-2H-Chromen-2-One, in Cellular and In Vivo Models of Pulmonary Oxidative Stress

John Yonchuk, Joseph P. Foley, Brian Bolognese et al. · Journal of Pharmacology and Experimental Therapeutics · 2017 · 20 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

1–3 of 3